In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance

por Wirth, Anna-Katharina, Wange, Lucas, Vosberg, Sebastian, Henrich, Kai-Oliver, Rausch, Christian, Özdemir, Erbey, Zeller, Christina M., Richter, Daniel, Feuchtinger, Tobias, Kaller, Markus, Hermeking, Heiko, Greif, Philipp A., Senft, Daniela, Jurinovic, Vindi, Bahrami, Ehsan, Jayavelu, Ashok Kumar, Westermann, Frank, Mann, Matthias, Enard, Wolfgang, Herold, Tobias, Jeremias, Irmela
Publicado 2022

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia

por Ebinger, Sarah, Özdemir, Erbey Ziya, Ziegenhain, Christoph, Tiedt, Sebastian, Castro Alves, Catarina, Grunert, Michaela, Dworzak, Michael, Lutz, Christoph, Turati, Virginia A., Enver, Tariq, Horny, Hans-Peter, Sotlar, Karl, Parekh, Swati, Spiekermann, Karsten, Hiddemann, Wolfgang, Schepers, Aloys, Polzer, Bernhard, Kirsch, Stefan, Hoffmann, Martin, Knapp, Bettina, Hasenauer, Jan, Pfeifer, Heike, Panzer-Grümayer, Renate, Enard, Wolfgang, Gires, Olivier, Jeremias, Irmela
Publicado 2016